A hand on your shoulder usually feels harmless. But what if the lightest touch, the pressure of clothing on your skin, or even a blanket resting on your body felt like sharp pain? For people living with chronic nerve pain, that’s not an exaggeration. It’s daily life, because the brain can start treating harmless touch signals as if they were a threat.
Researchers at the University of Colorado Boulder now describe a brain circuit that may help explain why short-term pain can turn into a long-lasting problem. In their work, one small part of the brain appears to act almost like a switch, keeping the body’s pain alarm on even after the original injury has faded.
A Sugar Cube-Sized Brain Region May Help Decide Whether Pain Fades or Lasts for Years
According to the U.S. Centers for Disease Control and Prevention, chronic pain affects nearly one in four American adults. About one in twelve adults has pain that frequently interferes with daily life or work.
The Colorado team focused on a brain region called the caudal granular insular cortex, or CGIC. It’s a small cluster of cells, roughly the size of a sugar cube, hidden deep within the folds of the insula.
This small structure may help determine whether temporary pain settles down or becomes chronic suffering that lasts for months or years. When researchers quieted this pathway in rats, chronic pain eased. That makes the CGIC more than just another obscure brain region. It may be one of the control points that helps keep the pain signal alive.
Senior author Linda Watkins, a distinguished professor of behavioral neuroscience at CU Boulder, said the team used advanced methods to identify the specific circuit involved in the transition from temporary pain to chronic pain. In the study, this circuit also appeared to send instructions down to the spinal cord, effectively telling the system to keep the pain going.
Why Even a Gentle Touch Can Start Feeling Like an Actual Injury
Acute pain and chronic pain don’t work the same way. Acute pain is a temporary warning signal. If you stub your toe, injured tissue sends a message to the spinal cord, and that message travels onward to the brain. Chronic pain is different. It behaves more like a false alarm, with pain signals continuing for weeks, months, or years after the original injury has healed.
The researchers used fluorescent proteins to track which cells became active after rats sustained a sciatic nerve injury. They found that the CGIC played only a small role in acute pain, but a much more important role in making pain persist.
The CGIC sends signals to the somatosensory cortex, the part of the brain that processes touch and body sensations. That region then influences the spinal cord in a way that keeps the pain signal active. The result is disturbing but important. A normal touch, something you would barely notice under ordinary conditions, can start being processed as pain.
That condition is called allodynia. In simple terms, it means the nervous system has become so hypersensitive that it mistakes harmless contact for danger. A shirt rubbing against the skin, a bedsheet touching the leg, or a gentle hand on the arm can feel painful instead of neutral.
When Scientists Quieted This Brain Circuit, Chronic Pain Eased in Animals
When the researchers turned off cells in this pathway right after injury, pain in the rats remained short-lived. In animals that were already experiencing chronic allodynia, quieting the same pathway caused the pain behavior to stop.
That doesn’t mean scientists have found a ready-made treatment for people with chronic pain. The study was done in animals, not in patients, and researchers still don’t know what first pushes the CGIC into sending chronic pain signals. More work is needed before the finding can be translated into human medicine.
“Our research presents a clear case that specific brain pathways can be directly targeted to modulate sensory pain,” said Jayson Ball, the study’s first author, who now works at Neuralink.
New Pain Treatments Could One Day Reduce the Need for Opioids
The authors are careful about the distance between a rat study and a treatment that doctors could use in people. That path is still long. Still, the research points to an important shift in how chronic pain might be understood. If scientists can identify the exact brain cells that keep pain switched on, future therapies may not need to dampen the entire nervous system. They may be able to target the circuit that keeps the pain alarm running.
This is where new approaches could become important. Ball has discussed the possibility of injections, infusions, or brain interfaces that could one day act on specific groups of neurons. That would be very different from conventional painkillers, which often affect broad systems throughout the body.
The study, published in the Journal of Neuroscience, used chemogenetic tools that allowed the team to switch selected groups of neurons on and off. For a general reader, it’s a bit like an electrician looking for one faulty wire instead of shutting down the power to the whole house.
Ball argues that these tools are changing the pace of pain research because scientists can now work with very specific populations of brain cells, not just broad brain regions. That matters because chronic pain may not be one simple signal traveling from an injured body part to the brain. It may become a self-sustaining loop inside the nervous system.
The key takeaway from the study is not that researchers have discovered an immediate cure for chronic pain. It is that pain lasting for months or years may not be only an echo of a damaged nerve. It may also be the result of the brain taking control of the body’s alarm system and refusing to turn it off.
